AGP Executive Report
Last update: 11 hours agoEye & Sleep Wellness: A new Taiwan-focused wellness explainer highlights how blue light blocking glasses may ease screen-related eye strain and support evening melatonin for better sleep—while stressing they’re not a substitute for proper vision correction. Disaster-Ready Health Systems: Taiwan ran a 30-minute drill throttling mobile data across seven central jurisdictions to test continuity for hospitals, police, firefighters and other services; calls and texts stayed active, but the exercise showed how vulnerable smartphone-dependent systems can be. Infectious Disease Watch: Ireland’s tropical illnesses are rising, with coverage pointing to increased travel and NGO missions as key drivers behind malaria, dengue, typhoid, mpox and other infections. Clinical Research & Cancer Care: A Taiwan-linked report discusses early predictors for successful conversion in advanced hepatocellular carcinoma using HAIC-based triple therapy, aiming to identify who may benefit from surgery after downstaging. Diabetes Complications: Energenesis Biomedical and Taiwan Tanabe signed a joint development deal for a topical drug targeting diabetic foot ulcers, supporting a potential Taiwan NDA. Ophthalmology Safety Signal: A study flags that tadalafil use for lower urinary tract symptoms was associated with higher glaucoma risk over five years, adding to eye-safety conversations around common medications.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Accelerometer Medical Sensors Market Size/Share Worth USD 2.93 Billion by 2034 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](https://ml.globenewswire.com/Resource/Download/6d1bbe3b-d9f1-4cae-9a02-2c4a48362517/accelerometer-medical-sensors-market.png)
![[Latest] Global Generative AI In Clinical Trials Market Size/Share Worth USD 1.86 Billion by 2035 at a 9.63% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/21273967-731329129-cmi-logo-png-100x51.png){kind=logo}
